Search Results
CodeBreak100: assessing sotorasib in patients with KRAS p.G12C-mutant pancreatic cancer
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation
Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
KRAS-mutant NSCLC: CodeBreak 100 trial of sotorasib
Phase II CodeBreak 100 trial of sotorasib in advanced NSCLC
KRYSTAL-1 and CodeBreak 100: targeting KRAS G12C in lung cancer
Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer
Evaluating the effects of the OPERA trial in clinical practice
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer
CodeBreaK100: detecting mechanisms of intrinsic resistance by ctDNA
Assessing the heterogeneity of KRAS-mutant pancreatic adenocarcinomas
